Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT02489760
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of AS, as defined by 1984 Modified New York Criteria for AS.
* Stable background therapy as non-steroid anti-inflammatory for 2 weeks.
* Stable glucocorticoid for 4 weeks.
* Stable disease-modifying anti-rheumatic drugs, eg. sulphasalazine, methotrexate for 8 weeks.
* Stable anti-TNF biologics for 4 weeks.
* Written informed consent.
Exclusion Criteria:
* Serum creatinine ≥3.0 mg/dl.
* GPT≥5 times the laboratory's upper limit of normal.
* Pregnant or breast-feeding women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02489760
Study Brief:
Protocol Section:
NCT02489760